CL2014003514A1 - Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central. - Google Patents

Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.

Info

Publication number
CL2014003514A1
CL2014003514A1 CL2014003514A CL2014003514A CL2014003514A1 CL 2014003514 A1 CL2014003514 A1 CL 2014003514A1 CL 2014003514 A CL2014003514 A CL 2014003514A CL 2014003514 A CL2014003514 A CL 2014003514A CL 2014003514 A1 CL2014003514 A1 CL 2014003514A1
Authority
CL
Chile
Prior art keywords
chitosan
peptides
transport
activity
nervous system
Prior art date
Application number
CL2014003514A
Other languages
English (en)
Inventor
Plessing Rossel Carlos Guillermo Von
Quiroga Eileen Valesta Castillo
Original Assignee
Univ De Concepción
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ De Concepción filed Critical Univ De Concepción
Priority to CL2014003514A priority Critical patent/CL2014003514A1/es
Publication of CL2014003514A1 publication Critical patent/CL2014003514A1/es
Priority to EP15871399.0A priority patent/EP3238716A4/en
Priority to PCT/CL2015/000067 priority patent/WO2016101081A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CL2014003514A 2014-12-23 2014-12-23 Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central. CL2014003514A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2014003514A CL2014003514A1 (es) 2014-12-23 2014-12-23 Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.
EP15871399.0A EP3238716A4 (en) 2014-12-23 2015-12-23 Nanoparticles based on chitosan for the transport of peptides with activity in the central nervous system
PCT/CL2015/000067 WO2016101081A1 (es) 2014-12-23 2015-12-23 Nano partículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003514A CL2014003514A1 (es) 2014-12-23 2014-12-23 Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.

Publications (1)

Publication Number Publication Date
CL2014003514A1 true CL2014003514A1 (es) 2015-05-08

Family

ID=53404122

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003514A CL2014003514A1 (es) 2014-12-23 2014-12-23 Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.

Country Status (3)

Country Link
EP (1) EP3238716A4 (es)
CL (1) CL2014003514A1 (es)
WO (1) WO2016101081A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112773941B (zh) * 2020-12-31 2022-09-16 东华大学 一种壳聚糖微球-细菌纤维素复合材料及其制备和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541046B1 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for protein drug delivery
KR101383324B1 (ko) * 2011-11-10 2014-04-28 주식회사 종근당 신규한 유전자 전달용 조성물

Also Published As

Publication number Publication date
WO2016101081A1 (es) 2016-06-30
EP3238716A1 (en) 2017-11-01
EP3238716A4 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
NL301224I2 (nl) Combinatie van foslevodopa en foscarbidopa, elk desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
IL249788A0 (en) Arrangement of a stand and drug release device containing it
IL252614A0 (en) Delivery of user-ad alerts
GB2522552B (en) Somatosensory type notification alerts
DK3204876T3 (da) Lægemiddelafgivelsesindretning
DK3220976T3 (da) Medikamenttilførselsanordning
IL249777A0 (en) Drug release device
ES2678679T8 (es) Sistema para estimulación eléctrica funcional
LT2943011T (lt) Belaidžio ryšio važiuojančioje transporto priemonėje sistema
IL250813A0 (en) Drug release device
DK3171921T3 (da) Lægemiddelafgivelsesindretning
SG11201604660VA (en) Drug delivery system.
HUE045234T2 (hu) Gyógyszeradagolás tanulása
IL249776A0 (en) Spring arrangement and drug release device containing it
AU360158S (en) Bottle with outer cage
EP3213736C0 (en) DRUG DELIVERY DEVICE
PL3142740T3 (pl) Urządzenia do dostarczania leku
ES3063918T3 (en) Drug delivery device with coaxially aligned rfid antennas
IL249789A0 (en) Drug release device
IL246874A0 (en) drug delivery system
EP3434251A4 (en) Drug container
CL2014003514A1 (es) Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central.
DK3240747T3 (da) Transportsystem
EP3102027A4 (en) Integrated dog tracking and stimulus delivery system
ES1120305Y (es) Sistema antirrobo de baterias